Veer Shah

522 total citations
12 papers, 307 citations indexed

About

Veer Shah is a scholar working on Biomedical Engineering, Materials Chemistry and Surgery. According to data from OpenAlex, Veer Shah has authored 12 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Biomedical Engineering, 3 papers in Materials Chemistry and 2 papers in Surgery. Recurrent topics in Veer Shah's work include Nanoparticles: synthesis and applications (3 papers), Laser-Ablation Synthesis of Nanoparticles (2 papers) and Bone Tissue Engineering Materials (2 papers). Veer Shah is often cited by papers focused on Nanoparticles: synthesis and applications (3 papers), Laser-Ablation Synthesis of Nanoparticles (2 papers) and Bone Tissue Engineering Materials (2 papers). Veer Shah collaborates with scholars based in United States, Mexico and Spain. Veer Shah's co-authors include Ebrahim Mostafavi, Ada Vernet-Crua, Jorge L. Cholula‐Díaz, David Medina-Cruz, Grégory Guisbiers, Thomas J. Webster, Hamed Barabadi, José Miguel García‐Martín, Vincent DeStefano and Marı́a Ujué González and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Nanomaterials.

In The Last Decade

Veer Shah

7 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Veer Shah United States 7 160 99 39 38 30 12 307
Saheb Ali India 11 202 1.3× 135 1.4× 69 1.8× 34 0.9× 15 0.5× 36 401
Felix Tettey United States 6 129 0.8× 76 0.8× 41 1.1× 24 0.6× 6 0.2× 9 266
Jingwen Gong China 11 84 0.5× 104 1.1× 36 0.9× 13 0.3× 42 1.4× 28 499
Arun Koyyada India 7 69 0.4× 140 1.4× 116 3.0× 32 0.8× 21 0.7× 12 382
Mansab Ali Saleemi Malaysia 11 161 1.0× 152 1.5× 53 1.4× 28 0.7× 5 0.2× 13 426
Kattakgoundar Govindaraj Sudha South Korea 10 198 1.2× 125 1.3× 44 1.1× 22 0.6× 6 0.2× 18 326
Rocío Guadalupe Casañas Pimentel Mexico 8 96 0.6× 106 1.1× 126 3.2× 33 0.9× 14 0.5× 19 288
Payal Kesharwani India 8 67 0.4× 154 1.6× 136 3.5× 29 0.8× 11 0.4× 14 445
Lingxiang Sun China 13 133 0.8× 136 1.4× 41 1.1× 29 0.8× 5 0.2× 31 357
N. Bhuvaneshwari India 6 134 0.8× 194 2.0× 87 2.2× 30 0.8× 7 0.2× 6 346

Countries citing papers authored by Veer Shah

Since Specialization
Citations

This map shows the geographic impact of Veer Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veer Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veer Shah more than expected).

Fields of papers citing papers by Veer Shah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veer Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veer Shah. The network helps show where Veer Shah may publish in the future.

Co-authorship network of co-authors of Veer Shah

This figure shows the co-authorship network connecting the top 25 collaborators of Veer Shah. A scholar is included among the top collaborators of Veer Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veer Shah. Veer Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Shah, Veer, Palak Shah, Alyson Haslam, et al.. (2025). Therapeutic anti-cancer vaccines: a systematic review of prospective intervention trials for common hematological malignancies. EClinicalMedicine. 86. 103378–103378.
3.
Shah, Veer, et al.. (2024). The clinical trials landscape in immunoglobulin light chain amyloidosis: a systematic review. Blood Advances. 8(13). 3464–3467.
4.
Seyyedsalehi, Monireh Sadat, et al.. (2024). Occupational Exposure to Benzene and Risk of Breast Cancer: Systematic Review and Meta-Analysis. ˜La œMedicina del lavoro. 115(5). e2024034–e2024034.
5.
DeStefano, Vincent, et al.. (2024). Abstract 835: Occupational-related exposure to benzene and risk of female genital cancers: Systematic review and meta-analysis. Cancer Research. 84(6_Supplement). 835–835.
6.
Shah, Veer, et al.. (2024). Polyaryletherketones: Properties and applications in modern medicine. SHILAP Revista de lepidopterología. 6. 75–89. 12 indexed citations
7.
Shah, Veer, et al.. (2023). PETG: Applications in Modern Medicine. SHILAP Revista de lepidopterología. 5(1). 45–55. 36 indexed citations
8.
Shah, Veer, David Medina-Cruz, Ada Vernet-Crua, et al.. (2022). Pepper-Mediated Green Synthesis of Selenium and Tellurium Nanoparticles with Antibacterial and Anticancer Potential. Journal of Functional Biomaterials. 14(1). 24–24. 20 indexed citations
9.
Medina-Cruz, David, Ada Vernet-Crua, Ebrahim Mostafavi, et al.. (2021). Aloe Vera-Mediated Te Nanostructures: Highly Potent Antibacterial Agents and Moderated Anticancer Effects. Nanomaterials. 11(2). 514–514. 31 indexed citations
10.
Medina-Cruz, David, Ebrahim Mostafavi, Ada Vernet-Crua, et al.. (2020). Green nanotechnology-based drug delivery systems for osteogenic disorders. Expert Opinion on Drug Delivery. 17(3). 341–356. 38 indexed citations
11.
Medina-Cruz, David, Ebrahim Mostafavi, Ada Vernet-Crua, et al.. (2020). Green nanotechnology-based zinc oxide (ZnO) nanomaterials for biomedical applications: a review. Journal of Physics Materials. 3(3). 34005–34005. 152 indexed citations
12.
Shah, Veer, et al.. (1987). Production of beta-human chorionic gonadotropin by prostatic adenocarcinoma and transitional cell carcinoma of the upper urinary tract.. PubMed. 68(6). 871–8. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026